Latest Indoco Remedies stock price
Indoco Remedies P/E Ratio
INDOCO • P/E ratio not applicable due to negative earnings
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company has been reporting losses for 4 consecutive quarters. P/E ratio cannot be calculated for loss-making companies.
Consecutive Loss Quarters: 4
Current EPS: ₹-8.46
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Sept 2025 | -1.00 | -9 | Loss |
| Mar 2025 | -4.48 | -41 | Loss |
| Jun 2025 | -3.94 | -36 | Loss |
| Sept 2024 | -1.09 | -10 | Loss |
| Mar 2024 | 2.39 | 22 | Profit |
| Jun 2024 | 0.20 | 2 | Profit |
| Dec 2024 | -3.08 | -28 | Loss |
| Sept 2023 | 3.82 | 35 | Profit |
Profitable Companies in Healthcare Sector
Other profitable companies in Healthcare sector with valid P/E ratios
Sector Average PE
50.44
Sector Median PE
36.54
Lowest PE
9.01
Profitable Companies
49
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Bliss GVS Pharma | BLISSGVS | 16.62 | ₹1,973 | Moderate |
| Gennex Laboratories | GENNEX | 17.99 | ₹329 | Moderate |
| Dr Reddys Laboratories | DRREDDY | 18.27 | ₹104,830 | Moderate |
| Zydus Life Science | ZYDUSLIFE | 18.63 | ₹93,333 | Moderate |
| Biofil Chemicals | BIOFILCHEM | 19.17 | ₹56 | Moderate |
| IOL Chemicals & Pharmace… | IOLCP | 20.62 | ₹2,389 | Moderate |
| Aurobindo Pharma | AUROPHARMA | 20.91 | ₹71,752 | Moderate |
| Strides Pharma Science | STAR | 21.99 | ₹9,007 | Moderate |